US5747334A
(en)
*
|
1990-02-15 |
1998-05-05 |
The University Of North Carolina At Chapel Hill |
Random peptide library
|
US5498538A
(en)
*
|
1990-02-15 |
1996-03-12 |
The University Of North Carolina At Chapel Hill |
Totally synthetic affinity reagents
|
US5639595A
(en)
*
|
1990-05-01 |
1997-06-17 |
Isis Phamaceuticals, Inc. |
Identification of novel drugs and reagents
|
US5650489A
(en)
*
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
US6197529B1
(en)
*
|
1990-11-21 |
2001-03-06 |
Torrey Pines Institute For Molecular Studies |
Linear substituted oligoalkyleneimine libraries
|
US20050209121A1
(en)
*
|
1990-12-05 |
2005-09-22 |
Novozymes A/S |
Proteins with changed epitopes and methods for the production thereof
|
US5646001A
(en)
*
|
1991-03-25 |
1997-07-08 |
Immunivest Corporation |
Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof
|
WO1993004204A1
(en)
*
|
1991-08-23 |
1993-03-04 |
Isis Pharmaceuticals, Inc. |
Synthetic unrandomization of oligomer fragments
|
WO1993005182A1
(en)
*
|
1991-09-05 |
1993-03-18 |
Isis Pharmaceuticals, Inc. |
Determination of oligonucleotides for therapeutics, diagnostics and research reagents
|
US5639603A
(en)
*
|
1991-09-18 |
1997-06-17 |
Affymax Technologies N.V. |
Synthesizing and screening molecular diversity
|
AU669489B2
(en)
*
|
1991-09-18 |
1996-06-13 |
Affymax Technologies N.V. |
Method of synthesizing diverse collections of oligomers
|
US6117974A
(en)
*
|
1991-10-02 |
2000-09-12 |
Peptor Limited |
Libraries of backbone-cyclized peptidomimetics
|
US20010021513A1
(en)
*
|
1991-11-21 |
2001-09-13 |
Puijk Wouter Cornelis |
Test device comprising a plate containing a multiplicity of wells with an associated metering device, as well as a kit which comprises these devices and use of the devices
|
US5573905A
(en)
*
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
ES2156869T5
(es)
*
|
1992-04-15 |
2008-07-01 |
The Johns Hopkins University |
Sintesis de colecciones diversas y utiles de oligonucleotidos.
|
US5541061A
(en)
*
|
1992-04-29 |
1996-07-30 |
Affymax Technologies N.V. |
Methods for screening factorial chemical libraries
|
WO1994002515A1
(en)
*
|
1992-07-21 |
1994-02-03 |
Bunsen Rush Laboratories Inc. |
Oligomer library formats and methods relating thereto
|
PT665897E
(pt)
*
|
1992-10-01 |
2003-11-28 |
Trustees Of Columbia U In The |
Bibliotecas quimicas combinatorias complexas codificadas com etiquetas
|
US6503759B1
(en)
|
1992-10-01 |
2003-01-07 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5721099A
(en)
*
|
1992-10-01 |
1998-02-24 |
Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5565324A
(en)
*
|
1992-10-01 |
1996-10-15 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5807683A
(en)
*
|
1992-11-19 |
1998-09-15 |
Combichem, Inc. |
Combinatorial libraries and methods for their use
|
DE4243770A1
(de)
*
|
1992-12-23 |
1994-06-30 |
Behringwerke Ag |
Verfahren zur Herstellung von rekombinanten und synthetischen Peptiden und deren Verwendung
|
US5605798A
(en)
*
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
WO1994020521A1
(de)
*
|
1993-03-12 |
1994-09-15 |
Jerini Bio Chemicals Gmbh |
Verfahren zur synthese und selektionierung von sequenzen aus kovalent verbundenen bausteinen
|
US6864048B2
(en)
|
1993-04-28 |
2005-03-08 |
Affymetrix, Inc. |
Factorial chemical libraries
|
US5840485A
(en)
*
|
1993-05-27 |
1998-11-24 |
Selectide Corporation |
Topologically segregated, encoded solid phase libraries
|
ES2204921T3
(es)
*
|
1993-05-27 |
2004-05-01 |
Selectide Corporation |
Bibliotecas de fase solida codificadas, segregadas topologicamente.
|
AU684510B2
(en)
*
|
1993-05-28 |
1997-12-18 |
Chiron Corporation |
Method for selection of biologically active peptide sequences
|
US5846731A
(en)
*
|
1993-06-17 |
1998-12-08 |
Torry Pines Institute For Molecular Studies |
Peralkylated oligopeptide mixtures
|
US5480971A
(en)
*
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
ATE210993T1
(de)
*
|
1993-06-21 |
2002-01-15 |
Selectide Corp |
Selektiv spaltbare verbindungen, die auf iminodiessigsäure-ester-bindungen basieren
|
WO1995001800A1
(en)
|
1993-07-09 |
1995-01-19 |
Smithkline Beecham Corporation |
Cyclic semi-random peptide libraries
|
AU7193494A
(en)
*
|
1993-07-21 |
1995-02-20 |
Oxford Glycosystems Ltd |
Saccharides, their synthesis and use
|
US6001982A
(en)
|
1993-07-29 |
1999-12-14 |
Isis Pharmaceuticals, Inc. |
Synthesis of oligonucleotides
|
DK0713533T3
(da)
*
|
1993-08-13 |
2002-11-04 |
Albany Molecular Res Inc |
Biokatalytiske metoder til syntese og identifikation af biologisk aktive forbindelser
|
CN1154640C
(zh)
*
|
1993-10-01 |
2004-06-23 |
纽约市哥伦比亚大学理事 |
用标示物编码的多元组合化学库
|
US5922545A
(en)
*
|
1993-10-29 |
1999-07-13 |
Affymax Technologies N.V. |
In vitro peptide and antibody display libraries
|
US5503805A
(en)
*
|
1993-11-02 |
1996-04-02 |
Affymax Technologies N.V. |
Apparatus and method for parallel coupling reactions
|
US6165778A
(en)
*
|
1993-11-02 |
2000-12-26 |
Affymax Technologies N.V. |
Reaction vessel agitation apparatus
|
US6287787B1
(en)
|
1993-11-24 |
2001-09-11 |
Torrey Pines Institute For Molecular Studies |
Dimeric oligopeptide mixture sets
|
EP0733213A1
(en)
*
|
1993-12-09 |
1996-09-25 |
Novartis AG |
Process for the production of combinatorial compound libraries
|
JPH09506611A
(ja)
*
|
1993-12-15 |
1997-06-30 |
コンビケム,インコーポレイテッド |
組合わせライブラリーおよびその使用法
|
US5587471A
(en)
*
|
1994-01-11 |
1996-12-24 |
Isis Pharmaceuticals, Inc. |
Method of making oligonucleotide libraries
|
ZA95260B
(en)
*
|
1994-01-13 |
1995-09-28 |
Univ Columbia |
Synthetic receptors libraries and uses thereof
|
US5593853A
(en)
*
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
US5541085A
(en)
*
|
1994-02-14 |
1996-07-30 |
Zymogenetics, Inc. |
Method for preparing orphan receptor ligands
|
US5539083A
(en)
*
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
ES2199247T3
(es)
*
|
1994-03-11 |
2004-02-16 |
Pharmacopeia Drug Discovery, Inc. |
Derivados de sulfonamida y su uso.
|
US6015880A
(en)
*
|
1994-03-16 |
2000-01-18 |
California Institute Of Technology |
Method and substrate for performing multiple sequential reactions on a matrix
|
US6936477B2
(en)
|
1994-04-13 |
2005-08-30 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5856083A
(en)
*
|
1994-05-06 |
1999-01-05 |
Pharmacopeia, Inc. |
Lawn assay for compounds that affect enzyme activity or bind to target molecules
|
US5846841A
(en)
*
|
1994-05-20 |
1998-12-08 |
Selectide Corporation |
Motif Libraries
|
IL109943A
(en)
*
|
1994-06-08 |
2006-08-01 |
Develogen Israel Ltd |
Conformationally constrained backbone cyclized peptide analogs
|
US6407059B1
(en)
|
1994-06-08 |
2002-06-18 |
Peptor Limited |
Conformationally constrained backbone cyclized peptide analogs
|
EP0765477A4
(en)
*
|
1994-06-14 |
2004-11-17 |
Smithkline Beecham Corp |
RESIN FOR THE TEST PHASE SYNTHESIS
|
US5663046A
(en)
*
|
1994-06-22 |
1997-09-02 |
Pharmacopeia, Inc. |
Synthesis of combinatorial libraries
|
US5817751A
(en)
*
|
1994-06-23 |
1998-10-06 |
Affymax Technologies N.V. |
Method for synthesis of diketopiperazine and diketomorpholine derivatives
|
WO1996000391A1
(en)
*
|
1994-06-23 |
1996-01-04 |
Affymax Technologies N.V. |
Methods for the synthesis of diketopiperazines
|
US5939268A
(en)
*
|
1994-07-26 |
1999-08-17 |
The Scripps Research Institute |
Combinatorial libraries of molecules and methods for producing same
|
MX9700725A
(es)
*
|
1994-07-26 |
1997-05-31 |
Scripps Research Inst |
Coleccion combinatoria soluble.
|
US5948693A
(en)
*
|
1994-09-01 |
1999-09-07 |
Wisconsin Alumni Research Foundation |
Solid phase synthesis of immunosuppressive agents
|
US5463564A
(en)
|
1994-09-16 |
1995-10-31 |
3-Dimensional Pharmaceuticals, Inc. |
System and method of automatically generating chemical compounds with desired properties
|
US6558633B1
(en)
|
1994-09-21 |
2003-05-06 |
Isis Pharmaceuticals, Inc. |
Chemical reaction apparatus and methods
|
USRE43097E1
(en)
|
1994-10-13 |
2012-01-10 |
Illumina, Inc. |
Massively parallel signature sequencing by ligation of encoded adaptors
|
US6280935B1
(en)
|
1994-10-13 |
2001-08-28 |
Lynx Therapeutics, Inc. |
Method of detecting the presence or absence of a plurality of target sequences using oligonucleotide tags
|
US5695934A
(en)
*
|
1994-10-13 |
1997-12-09 |
Lynx Therapeutics, Inc. |
Massively parallel sequencing of sorted polynucleotides
|
US5846719A
(en)
*
|
1994-10-13 |
1998-12-08 |
Lynx Therapeutics, Inc. |
Oligonucleotide tags for sorting and identification
|
US5604097A
(en)
*
|
1994-10-13 |
1997-02-18 |
Spectragen, Inc. |
Methods for sorting polynucleotides using oligonucleotide tags
|
EP0786085A4
(en)
*
|
1994-10-14 |
1999-02-03 |
Chiron Mimotopes Pty Ltd |
EFFICIENT METHOD OF DISCOVERING MIMOTOPES AND APPARATUS THEREOF
|
US5556752A
(en)
|
1994-10-24 |
1996-09-17 |
Affymetrix, Inc. |
Surface-bound, unimolecular, double-stranded DNA
|
US6974666B1
(en)
|
1994-10-21 |
2005-12-13 |
Appymetric, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US5688696A
(en)
*
|
1994-12-12 |
1997-11-18 |
Selectide Corporation |
Combinatorial libraries having a predetermined frequency of each species of test compound
|
DE4444260A1
(de)
*
|
1994-12-13 |
1996-06-20 |
Hoechst Ag |
Cyclohexapeptide und deren Mischungen, Verfahren zur Herstellung sowie deren Verwendung
|
WO1996022067A2
(en)
*
|
1994-12-27 |
1996-07-25 |
United Biomedical, Inc. |
Peptide ratchet libraries for ctl-inducing vaccines and therapeutics
|
GB9502225D0
(en)
*
|
1995-02-04 |
1995-03-22 |
Zeneca Ltd |
Method
|
US5759865A
(en)
*
|
1995-05-03 |
1998-06-02 |
Eli Lilly And Company |
Combinatorial process for synthesizing azetidinone analogs
|
AU5487496A
(en)
*
|
1995-05-03 |
1996-11-21 |
Eli Lilly And Company |
Combinatorial process for synthesizing azetidinone analogs
|
US5834318A
(en)
*
|
1995-05-10 |
1998-11-10 |
Bayer Corporation |
Screening of combinatorial peptide libraries for selection of peptide ligand useful in affinity purification of target proteins
|
US5830655A
(en)
|
1995-05-22 |
1998-11-03 |
Sri International |
Oligonucleotide sizing using cleavable primers
|
AU5871196A
(en)
*
|
1995-05-23 |
1996-12-24 |
Hybridon, Inc. |
Methods and compounds for the synthesis of oligonucleotides and the oligonucleotides thereby produced
|
US5750674A
(en)
*
|
1995-05-23 |
1998-05-12 |
Hybridon, Inc. |
Methods and compounds for the stereoselective enrichment of oligonucleotide diastereomers and oligonucleotides thereby produced
|
US20010053523A1
(en)
*
|
1995-06-02 |
2001-12-20 |
M&E Biotech A/S. |
Method for identification of biologically active peptides and nucleic acids
|
US5770687A
(en)
*
|
1995-06-07 |
1998-06-23 |
Peptor Limited |
Comformationally constrained backbone cyclized somatostatin analogs
|
US6051554A
(en)
*
|
1995-06-07 |
2000-04-18 |
Peptor Limited |
Conformationally constrained backbone cyclized somatostatin analogs
|
JPH11509086A
(ja)
*
|
1995-06-21 |
1999-08-17 |
マーテック・バイオサイエンシズ・コーポレイション |
標識生化学化合物の組合わせライブラリーとその作成方法
|
SE9502286D0
(sv)
*
|
1995-06-22 |
1995-06-22 |
Pharmacia Ab |
Process for detection, quantification and/or identification of a peptide
|
US6579848B1
(en)
*
|
1995-06-23 |
2003-06-17 |
The United States Of America As Represented By The Department Of Health And Human Services |
Depigmenting activity of agouti signal protein and peptides thereof
|
GB9515070D0
(en)
*
|
1995-07-22 |
1995-09-20 |
Zeneca Ltd |
Label
|
US6068829A
(en)
|
1995-09-11 |
2000-05-30 |
The Burnham Institute |
Method of identifying molecules that home to a selected organ in vivo
|
ATE195181T1
(de)
*
|
1995-09-11 |
2000-08-15 |
Jolla Cancer Res Found |
Moleküle, die sich in ausgewählten organen oder geweben invivo einfinden und verfahren zu ihrer identifizierung
|
US6743892B1
(en)
|
1995-09-11 |
2004-06-01 |
La Jolla Cancer Research Foundation |
Molecules that home to a selected organ in vivo
|
AU728668B2
(en)
*
|
1995-09-11 |
2001-01-18 |
La Jolla Cancer Research Foundation |
Molecules that home to a selected organ or tissue in vivo and methods of identifying same
|
US7026114B1
(en)
*
|
1995-09-13 |
2006-04-11 |
Affymetrix, Inc. |
Methods and compositions for monitoring polymer array synthesis
|
US6841533B1
(en)
|
1995-12-07 |
2005-01-11 |
Peptor Limited |
Conformationally constrained backbone cyclized interleukin-6 antagonists
|
US6147205A
(en)
*
|
1995-12-15 |
2000-11-14 |
Affymetrix, Inc. |
Photocleavable protecting groups and methods for their use
|
US20110028350A1
(en)
*
|
1995-12-15 |
2011-02-03 |
Affymetrix, Inc. |
Photocleavable protecting groups
|
US20030100007A1
(en)
*
|
1995-12-18 |
2003-05-29 |
Howard Benjamin |
Methods for identifying compounds that bind to a target
|
WO1997025983A1
(en)
*
|
1996-01-22 |
1997-07-24 |
Eli Lilly And Company |
Indane derivatives for antipsychotic compositions
|
EP1295952A3
(en)
|
1996-01-23 |
2003-07-09 |
The Board of Trustees of The Leland Stanford Junior University |
Methods for screening for transdominant effector peptides and RNA molecules
|
US6365344B1
(en)
*
|
1996-01-23 |
2002-04-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for screening for transdominant effector peptides and RNA molecules
|
US6277583B1
(en)
*
|
1996-02-07 |
2001-08-21 |
Conjuchem, Inc. |
Affinity labeling libraries and applications thereof
|
US6080719A
(en)
*
|
1996-02-23 |
2000-06-27 |
Hoechst Aktiengesellschaft |
Cyclohexapeptides and their mixtures, a process for preparing them, and their use
|
CA2248084A1
(en)
*
|
1996-03-04 |
1997-09-12 |
Genetrace Systems, Inc. |
Methods of screening nucleic acids using mass spectrometry
|
DE19610103A1
(de)
|
1996-03-15 |
1997-09-18 |
Basf Ag |
Cycloalkylderivate und ihre Synthese an fester Phase
|
EP0954601A4
(en)
*
|
1996-03-20 |
2004-08-18 |
Genzyme Corp |
METHOD FOR DETECTING CYTOTOXIC T-CELL EPITOPES
|
EP0901629A4
(en)
*
|
1996-03-21 |
2000-02-02 |
Univ Princeton |
CARBOHYDRATE LIBRARY, ASSAY AND METHOD
|
US5866341A
(en)
*
|
1996-04-03 |
1999-02-02 |
Chugai Pharmaceutical Co., Ltd. |
Compositions and methods for screening drug libraries
|
US7144119B2
(en)
|
1996-04-25 |
2006-12-05 |
Bioarray Solutions Ltd. |
System and method for programmable illumination pattern generation
|
US6387707B1
(en)
|
1996-04-25 |
2002-05-14 |
Bioarray Solutions |
Array Cytometry
|
ATE366418T1
(de)
*
|
1996-04-25 |
2007-07-15 |
Bioarray Solutions Ltd |
Licht-regulierte, elektrokinetische zusammensetzung von partikeln an oberflächen
|
US5958342A
(en)
*
|
1996-05-17 |
1999-09-28 |
Incyte Pharmaceuticals, Inc. |
Jet droplet device
|
DE19621177A1
(de)
|
1996-05-24 |
1997-11-27 |
Basf Ag |
Kohlenhydratderivate und ihre Synthese an fester Phase
|
US6203978B1
(en)
*
|
1996-05-31 |
2001-03-20 |
Du Vergier Ltd. |
Capture of single stranded nucleic acids
|
US6696251B1
(en)
|
1996-05-31 |
2004-02-24 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6300065B1
(en)
|
1996-05-31 |
2001-10-09 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
CN1227566A
(zh)
|
1996-06-14 |
1999-09-01 |
明治乳业株式会社 |
T细胞表位肽
|
AU3307497A
(en)
*
|
1996-06-26 |
1998-01-14 |
Antigen Express, Inc. |
Immunotherapy by modulation of antigen presentation
|
DE19626762A1
(de)
|
1996-07-03 |
1998-01-08 |
Basf Ag |
Enzymatisch spaltbare Linker für Festphasensynthesen
|
US6355613B1
(en)
|
1996-07-31 |
2002-03-12 |
Peptor Limited |
Conformationally constrained backbone cyclized somatostatin analogs
|
US5922872A
(en)
*
|
1996-08-01 |
1999-07-13 |
Isis Pharmaceuticals, Inc. |
Meta-benzylic and alpha-amido compositions and methods for preparing same
|
US5817489A
(en)
*
|
1996-08-01 |
1998-10-06 |
Isis Pharmaceuticals, Inc. |
Di-nitrogen heterocycle compositions
|
US6576239B1
(en)
|
1996-09-10 |
2003-06-10 |
The Burnham Institute |
Angiogenic homing molecules and conjugates derived therefrom
|
WO1998011437A1
(en)
|
1996-09-16 |
1998-03-19 |
Conjuchem, Inc. |
Affinity labeling libraries with tagged leaving groups
|
US5965363A
(en)
|
1996-09-19 |
1999-10-12 |
Genetrace Systems Inc. |
Methods of preparing nucleic acids for mass spectrometric analysis
|
US5798035A
(en)
|
1996-10-03 |
1998-08-25 |
Pharmacopeia, Inc. |
High throughput solid phase chemical synthesis utilizing thin cylindrical reaction vessels useable for biological assay
|
US20020022227A1
(en)
*
|
1996-10-17 |
2002-02-21 |
Short Jay M. |
Morphatides: novel shape and structure libraries
|
US6838238B1
(en)
*
|
1996-10-17 |
2005-01-04 |
Invitrogen Corporation |
Morphatides: novel shape and structure libraries
|
US6149869A
(en)
*
|
1996-10-23 |
2000-11-21 |
Glaxo Wellcome Inc. |
Chemical synthesizers
|
US6042789A
(en)
*
|
1996-10-23 |
2000-03-28 |
Glaxo Group Limited |
System for parallel synthesis of organic compounds
|
US6413724B1
(en)
|
1996-10-28 |
2002-07-02 |
Versicor, Inc. |
Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
|
US6025371A
(en)
*
|
1996-10-28 |
2000-02-15 |
Versicor, Inc. |
Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
|
US6571227B1
(en)
|
1996-11-04 |
2003-05-27 |
3-Dimensional Pharmaceuticals, Inc. |
Method, system and computer program product for non-linear mapping of multi-dimensional data
|
US6453246B1
(en)
|
1996-11-04 |
2002-09-17 |
3-Dimensional Pharmaceuticals, Inc. |
System, method, and computer program product for representing proximity data in a multi-dimensional space
|
IL129728A0
(en)
|
1996-11-04 |
2000-02-29 |
Dimensional Pharm Inc |
System method and computer program product for the visualization and interactive processing and analysis of chemical data
|
US6054325A
(en)
*
|
1996-12-02 |
2000-04-25 |
Glaxo Wellcom Inc. |
Method and apparatus for transferring and combining distinct chemical compositions with reagents
|
US6083761A
(en)
*
|
1996-12-02 |
2000-07-04 |
Glaxo Wellcome Inc. |
Method and apparatus for transferring and combining reagents
|
WO1998024760A1
(en)
*
|
1996-12-03 |
1998-06-11 |
Graybill Todd L |
Aminobenzenedicarboxylic acid-based combinatorial libraries
|
EP0963443B1
(en)
|
1996-12-10 |
2006-03-08 |
Sequenom, Inc. |
Releasable nonvolatile mass-label molecules
|
EP0975792B1
(en)
*
|
1997-03-04 |
2007-10-10 |
Savient Pharmaceuticals, Inc. |
Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
|
US6045755A
(en)
*
|
1997-03-10 |
2000-04-04 |
Trega Biosciences,, Inc. |
Apparatus and method for combinatorial chemistry synthesis
|
US6177464B1
(en)
|
1997-03-14 |
2001-01-23 |
Sepracor, Inc. |
Ring opening metathesis of alkenes
|
US7622294B2
(en)
|
1997-03-14 |
2009-11-24 |
Trustees Of Tufts College |
Methods for detecting target analytes and enzymatic reactions
|
US20030027126A1
(en)
|
1997-03-14 |
2003-02-06 |
Walt David R. |
Methods for detecting target analytes and enzymatic reactions
|
JPH10260223A
(ja)
*
|
1997-03-19 |
1998-09-29 |
Fujitsu Ltd |
半導体検査装置及びこれを用いた検査方法
|
JP2002506423A
(ja)
*
|
1997-04-11 |
2002-02-26 |
イーライ・リリー・アンド・カンパニー |
ペプチド模倣型大員環のコンビナトリアルライブラリーとそのための方法
|
US6004823A
(en)
*
|
1997-05-07 |
1999-12-21 |
Smithkline Beecham Corporation |
Compounds
|
US5908960A
(en)
*
|
1997-05-07 |
1999-06-01 |
Smithkline Beecham Corporation |
Compounds
|
GB9710582D0
(en)
|
1997-05-22 |
1997-07-16 |
Oxford Glycosciences Uk Ltd |
A method for de novo peptide sequence determination
|
JP4302780B2
(ja)
*
|
1997-05-23 |
2009-07-29 |
バイオアレイ ソリューションズ エルエルシー |
マトリックスで結合された化合物の色別コード化とインシトゥ探索
|
AU8147798A
(en)
*
|
1997-06-16 |
1999-01-04 |
University Of North Carolina At Chapel Hill, The |
Peptido oligonucleotides (pons) and their combinatorial libraries
|
EP1387390B1
(en)
|
1997-06-20 |
2009-02-18 |
Bio - Rad Laboratories, Inc. |
Retentate chromatography and protein chip arrays with applications in biology and medicine
|
NZ516848A
(en)
|
1997-06-20 |
2004-03-26 |
Ciphergen Biosystems Inc |
Retentate chromatography apparatus with applications in biology and medicine
|
US5874589A
(en)
*
|
1997-07-18 |
1999-02-23 |
Glaxo Wellcome, Inc. |
Methods for synthesizing diverse collections of tetramic acids and derivatives thereof
|
US6410342B1
(en)
*
|
1997-08-19 |
2002-06-25 |
Pharmacopeia, Inc. |
Method and apparatus for controlled photoelution
|
US7252950B1
(en)
|
1997-09-04 |
2007-08-07 |
The Regents Of The University Of California |
Assays for detecting modulators of cytoskeletal function
|
US6960457B1
(en)
|
1997-09-04 |
2005-11-01 |
Stanford University |
Reversible immobilization of arginine-tagged moieties on a silicate surface
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
CA2628053A1
(en)
|
1997-11-07 |
1999-05-20 |
Conjuchem Biotechnologies Inc. |
Affinity markers for human serum albumin
|
US6228579B1
(en)
*
|
1997-11-14 |
2001-05-08 |
San Diego State University Foundation |
Method for identifying microbial proliferation genes
|
US6083682A
(en)
|
1997-12-19 |
2000-07-04 |
Glaxo Group Limited |
System and method for solid-phase parallel synthesis of a combinatorial collection of compounds
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US5968361A
(en)
*
|
1998-02-24 |
1999-10-19 |
Arqule, Inc. |
Rapid method for separation of small molecules using reverse phase high performance liquid chromatography
|
US6497820B1
(en)
|
1998-02-03 |
2002-12-24 |
Arqule, Inc. |
Rapid method for separation of small molecules using reverse phase high performance liquid chromatography
|
AU2795399A
(en)
*
|
1998-02-27 |
1999-09-15 |
Isis Pharmaceuticals, Inc. |
Hplc fractionation of complex chemical mixtures
|
US6232287B1
(en)
|
1998-03-13 |
2001-05-15 |
The Burnham Institute |
Molecules that home to various selected organs or tissues
|
WO1999047923A2
(en)
|
1998-03-20 |
1999-09-23 |
The Rockefeller University |
Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
|
AU767185B2
(en)
|
1998-03-23 |
2003-11-06 |
President And Fellows Of Harvard College |
Synthesis of compounds and libraries of compounds
|
KR20010042373A
(ko)
*
|
1998-03-30 |
2001-05-25 |
린다 에스. 스티븐슨 |
핵 수용체 활성을 조절하는 방법 및 화합물
|
US6316616B1
(en)
|
1998-04-02 |
2001-11-13 |
President And Fellows Of Harvard College |
Parallel combinatorial approach to the discovery and optimization of catalysts and uses thereof
|
US6699969B1
(en)
|
1998-04-14 |
2004-03-02 |
The Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US6410687B1
(en)
|
1998-04-14 |
2002-06-25 |
The Regents Of The University Of California |
Polypeptides for the detection of microtubule depolymerization inhibitors
|
US6872537B1
(en)
|
1998-04-14 |
2005-03-29 |
Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
HUP0101828A3
(en)
|
1998-05-04 |
2005-08-29 |
Fraunhofer Ges Forschung |
Electrical integrated nucleic acid isolation, purification and detection
|
DE19819889A1
(de)
*
|
1998-05-04 |
1999-11-11 |
Fraunhofer Ges Forschung |
Verfahren zur Isolierung von Nucleinsäuren
|
EP1138692A1
(en)
|
2000-03-29 |
2001-10-04 |
Erasmus Universiteit Rotterdam |
Fragments of human chorionic gonadotropin (hcg) as immunoregulator
|
US6541211B1
(en)
|
1998-05-20 |
2003-04-01 |
Selectide Corporation |
Apparatus and method for synthesizing combinational libraries
|
US6872535B2
(en)
|
1998-05-20 |
2005-03-29 |
Aventis Pharmaceuticals Inc. |
Three-dimensional array of supports for solid-phase parallel synthesis and method of use
|
US7387779B2
(en)
*
|
1998-06-17 |
2008-06-17 |
Beth Israel Deaconess Medical Center |
Anti-angiogenic proteins and fragments and methods of use thereof
|
US7402400B2
(en)
|
2001-07-03 |
2008-07-22 |
Regents Of The University Of California |
Mammalian sweet taste receptors
|
US6602685B1
(en)
|
1998-08-17 |
2003-08-05 |
Phylos, Inc. |
Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
|
US6633543B1
(en)
*
|
1998-08-27 |
2003-10-14 |
Intel Corporation |
Multicast flow control
|
US20040242521A1
(en)
*
|
1999-10-25 |
2004-12-02 |
Board Of Regents, The University Of Texas System |
Thio-siRNA aptamers
|
US6423493B1
(en)
*
|
1998-10-26 |
2002-07-23 |
Board Of Regents The University Of Texas System |
Combinatorial selection of oligonucleotide aptamers
|
WO2000027627A1
(en)
*
|
1998-11-12 |
2000-05-18 |
Eli Lilly And Company |
Aryloxime linkers in the solid-phase synthesis of 3-aminobenzisoxazoles
|
US20030027214A1
(en)
*
|
1999-02-17 |
2003-02-06 |
Kamb Carl Alexander |
Methods for substrate-ligand interaction screening
|
WO2000073799A1
(en)
|
1999-06-01 |
2000-12-07 |
Caliper Technologies Corp. |
Microscale assays and microfluidic devices for transporter, gradient induced, and binding activities
|
ATE296350T1
(de)
|
1999-06-14 |
2005-06-15 |
Genentech Inc |
Strukturiertes peptidgerüst zur ausstellung von drehung-bibliotheken auf phage
|
SE9902479D0
(sv)
*
|
1999-06-30 |
1999-06-30 |
Amersham Pharm Biotech Ab |
Particle classification as marker
|
US7742877B1
(en)
|
1999-07-22 |
2010-06-22 |
Becton, Dickinson & Company |
Methods, apparatus and computer program products for formulating culture media
|
US7604996B1
(en)
*
|
1999-08-18 |
2009-10-20 |
Illumina, Inc. |
Compositions and methods for preparing oligonucleotide solutions
|
DK1207905T3
(da)
|
1999-09-03 |
2011-01-03 |
Brigham & Womens Hospital |
Fremgangsmåder og sammensætninger til behandling af inflammatorisk sygdom under anvendelse af cadherin-II modulerende midler
|
AU7856600A
(en)
|
1999-10-04 |
2001-05-10 |
University Of Medicine And Dentistry Of New Jersey |
Novel carbamates and ureas
|
US6569685B1
(en)
|
1999-10-05 |
2003-05-27 |
The Molecular Sciences Institute, Inc. |
Protein fingerprint system and related methods
|
KR100378252B1
(ko)
*
|
1999-11-12 |
2003-03-29 |
학교법인 포항공과대학교 |
니트로술포닐에톡시카르보닐-아미노산을 이용한 합성테트라펩티드 라이브러리의 제조방법
|
US6458538B1
(en)
|
1999-12-14 |
2002-10-01 |
Ptc Therapeutics, Inc. |
Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay
|
US8642284B1
(en)
|
1999-12-15 |
2014-02-04 |
Massachusetts Institute Of Technology |
Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein
|
US7452664B2
(en)
|
1999-12-15 |
2008-11-18 |
Massachusetts Institute Of Technology |
Methods for identifying agents which alter histone protein acetylation
|
US7022479B2
(en)
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
EP1250463B1
(en)
|
2000-01-24 |
2006-04-05 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
AU2000234813A1
(en)
|
2000-02-03 |
2001-08-14 |
The Regents Of The University Of California |
Assays for the detection of agents that affect cognition
|
US7416524B1
(en)
|
2000-02-18 |
2008-08-26 |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
System, method and computer program product for fast and efficient searching of large chemical libraries
|
US6671627B2
(en)
|
2000-02-29 |
2003-12-30 |
3-D Pharmaceuticals, Inc. |
Method and computer program product for designing combinatorial arrays
|
TW201006846A
(en)
|
2000-03-07 |
2010-02-16 |
Senomyx Inc |
T1R taste receptor and genes encidung same
|
US7039621B2
(en)
|
2000-03-22 |
2006-05-02 |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
System, method, and computer program product for representing object relationships in a multidimensional space
|
USRE43279E1
(en)
|
2000-03-29 |
2012-03-27 |
Biotemp B.V. |
Compositions capable of reducing elevated blood urea concentration
|
US20050037430A1
(en)
*
|
2000-03-29 |
2005-02-17 |
Biotempt B.V. |
Methods and uses for protein breakdown products
|
AU2001249805A1
(en)
|
2000-04-03 |
2001-10-15 |
3-Dimensional Pharmaceuticals, Inc. |
Method, system, and computer program product for representing object relationships in a multidimensional space
|
US7255999B2
(en)
|
2001-05-21 |
2007-08-14 |
Monogram Biosciences, Inc. |
Methods and compositions for analyzing proteins
|
AU2001268468A1
(en)
|
2000-06-13 |
2001-12-24 |
The Trustees Of Boston University |
Use of nucleotide analogs in the analysis of oligonucleotide mixtures and in highly multiplexed nucleic acid sequencing
|
AU7299301A
(en)
|
2000-06-21 |
2002-01-02 |
Bioarray Solutions Ltd |
Multianalyte molecular analysis using application-specific random particle arrays
|
US9709559B2
(en)
|
2000-06-21 |
2017-07-18 |
Bioarray Solutions, Ltd. |
Multianalyte molecular analysis using application-specific random particle arrays
|
US6759510B1
(en)
*
|
2000-06-30 |
2004-07-06 |
Becton, Dickinson And Company |
Peptides for use in culture media
|
US20020019011A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Stockwell Brent R. |
Methods for identifying combinations of entities as therapeutics
|
US20020051991A1
(en)
*
|
2000-07-11 |
2002-05-02 |
Zhi Hong |
Rapid generation of diverse nucleoside and nucleotide libraries
|
CA2419159A1
(en)
*
|
2000-08-11 |
2002-02-21 |
Agilix Corporation |
Ultra-sensitive detection systems
|
US6963807B2
(en)
|
2000-09-08 |
2005-11-08 |
Oxford Glycosciences (Uk) Ltd. |
Automated identification of peptides
|
US7420030B2
(en)
|
2000-09-08 |
2008-09-02 |
The Board Of Regents Of The University Of Texas System |
Aminopeptidase A (APA) targeting peptides for the treatment of cancer
|
US20040170955A1
(en)
|
2000-09-08 |
2004-09-02 |
Wadih Arap |
Human and mouse targeting peptides identified by phage display
|
US7452964B2
(en)
|
2001-09-07 |
2008-11-18 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides against placenta and adipose tissues
|
EP1325017A2
(en)
*
|
2000-09-11 |
2003-07-09 |
Affymetrix, Inc. |
Photocleavable protecting groups
|
EP1332371A2
(en)
*
|
2000-09-18 |
2003-08-06 |
Genzyme Corporation |
Method to identify antibody targets based on mass spectrometry (maldi-tof)
|
EP1326997A4
(en)
|
2000-09-25 |
2006-01-11 |
Univ |
MODEL FOR NEURODEGENERATIVE DISEASES WITH AMYLOIDAC CUMULATION
|
US20030045005A1
(en)
|
2000-10-17 |
2003-03-06 |
Michael Seul |
Light-controlled electrokinetic assembly of particles near surfaces
|
US7045283B2
(en)
|
2000-10-18 |
2006-05-16 |
The Regents Of The University Of California |
Methods of high-throughput screening for internalizing antibodies
|
US20020165149A1
(en)
*
|
2000-12-08 |
2002-11-07 |
Kranz David M. |
Mutated class II major histocompatibility proteins
|
US7572575B2
(en)
|
2000-12-13 |
2009-08-11 |
Massachusetts Institute Of Technology |
SIR2 activity
|
JP2005502309A
(ja)
|
2000-12-23 |
2005-01-27 |
カイロン コーポレイション |
オリゴヌクレオチドトランスフェクションスクリーニング方法
|
TW201022287A
(en)
|
2001-01-03 |
2010-06-16 |
Senomyx Inc |
T1R taste receptors and genes encoding same
|
WO2002061419A1
(en)
|
2001-01-29 |
2002-08-08 |
3-Dimensional Pharmaceuticals, Inc. |
Method, system, and computer program product for analyzing combinatorial libraries
|
DE10106339A1
(de)
*
|
2001-02-09 |
2002-08-22 |
Hans-Joachim Mueller |
Verfahren zum Hochdurchsatz-Screening von Kandidaten-Verbindungen über die Hochdurchsatz-Direktsynthese von rekombinanten Polypeptiden
|
US7883856B2
(en)
|
2001-04-05 |
2011-02-08 |
Senomyx Inc. |
Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
|
US20030191073A1
(en)
|
2001-11-07 |
2003-10-09 |
Challita-Eid Pia M. |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
|
US20060228730A1
(en)
*
|
2001-04-11 |
2006-10-12 |
Rando Robert F |
Methods for identifying small molecules that bind specific RNA structural motifs
|
US20050142545A1
(en)
*
|
2001-04-11 |
2005-06-30 |
Conn Michael M. |
Methods for identifying small molecules that bind specific rna structural motifs
|
WO2002083822A2
(en)
*
|
2001-04-13 |
2002-10-24 |
Mitrovich Michael J |
Solid lubricant and composition
|
US6914123B2
(en)
|
2001-04-17 |
2005-07-05 |
Genentech, Inc. |
Hairpin peptides with a novel structural motif and methods relating thereto
|
US7803982B2
(en)
|
2001-04-20 |
2010-09-28 |
The Mount Sinai School Of Medicine Of New York University |
T1R3 transgenic animals, cells and related methods
|
US20030113714A1
(en)
*
|
2001-09-28 |
2003-06-19 |
Belcher Angela M. |
Biological control of nanoparticles
|
US20050164515A9
(en)
*
|
2001-06-05 |
2005-07-28 |
Belcher Angela M. |
Biological control of nanoparticle nucleation, shape and crystal phase
|
US20030148380A1
(en)
*
|
2001-06-05 |
2003-08-07 |
Belcher Angela M. |
Molecular recognition of materials
|
WO2002100172A1
(en)
|
2001-06-11 |
2002-12-19 |
Xenoport, Inc. |
Administration of agents via the pept-2 transporter
|
EP1401850A1
(en)
|
2001-06-20 |
2004-03-31 |
Nuevolution A/S |
Nucleoside derivatives for library preparation
|
US7262063B2
(en)
|
2001-06-21 |
2007-08-28 |
Bio Array Solutions, Ltd. |
Directed assembly of functional heterostructures
|
EP2293067B1
(en)
|
2001-06-26 |
2016-04-20 |
Senomyx, Inc. |
T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
|
JP4351043B2
(ja)
|
2001-07-09 |
2009-10-28 |
エラン ファーマシューティカルズ,インコーポレイテッド |
アミロイド毒性の阻害方法
|
US6800449B1
(en)
*
|
2001-07-13 |
2004-10-05 |
Syngenta Participations Ag |
High throughput functional proteomics
|
US7413870B2
(en)
|
2001-08-01 |
2008-08-19 |
Rigel Pharmaceuticals, Incorporated |
SAK: modulation of cellular proliferation for treatment of cancer
|
US6767731B2
(en)
*
|
2001-08-27 |
2004-07-27 |
Intel Corporation |
Electron induced fluorescent method for nucleic acid sequencing
|
TW573125B
(en)
*
|
2001-08-29 |
2004-01-21 |
Combinatorx Inc |
A screening system for identifying drug-drug interactions and methods of use thereof
|
US20030073104A1
(en)
*
|
2001-10-02 |
2003-04-17 |
Belcher Angela M. |
Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
|
JP4377689B2
(ja)
|
2001-10-15 |
2009-12-02 |
バイオアレイ ソリューションズ リミテッド |
同時尋問及び酵素仲介検出による多型遺伝子座の複合分析
|
EP1440083B1
(en)
|
2001-10-25 |
2013-01-02 |
Medical Research Council |
Molecules
|
US6670142B2
(en)
|
2001-10-26 |
2003-12-30 |
The Regents Of The University Of California |
Method for screening combinatorial bead library, capturing cells from body fluids, and ligands for cancer cells
|
US7262269B2
(en)
|
2001-10-26 |
2007-08-28 |
The Regents Of University Of California |
Method for screening combinational bead library; ligands for cancer cells
|
US20030124595A1
(en)
*
|
2001-11-06 |
2003-07-03 |
Lizardi Paul M. |
Sensitive coded detection systems
|
DE60232688D1
(de)
*
|
2001-11-20 |
2009-07-30 |
Univ Duke |
Grenzflächen-biomaterialien
|
US7871619B2
(en)
|
2001-11-30 |
2011-01-18 |
Chemocentryx, Inc. |
Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
|
WO2003052053A2
(en)
*
|
2001-12-17 |
2003-06-26 |
Ribapharm Inc. |
Nucleoside libraries and compounds by mcc combinatorial strategies on solid support
|
US7291456B2
(en)
|
2002-01-24 |
2007-11-06 |
The Regents Of The University Of California |
Method for determining differences in molecular interactions and for screening a combinatorial library
|
JP2005516336A
(ja)
*
|
2002-01-28 |
2005-06-02 |
バースタイン テクノロジーズ,インコーポレイティド |
論理的なトリガのための方法および装置
|
US7251210B2
(en)
*
|
2002-01-31 |
2007-07-31 |
Burstein Technologies, Inc. |
Method for triggering through disc grooves and related optical analysis discs and system
|
AU2003209054A1
(en)
*
|
2002-02-07 |
2003-09-02 |
Discovery Genomics, Inc. |
Factors for angiogenesis, vasculogenesis, cartilage formation, bone formation and methods of use thereof
|
AU2003213676A1
(en)
|
2002-03-04 |
2003-09-22 |
Bristol-Myers Squibb Company |
Novel nucleic acid molecules and polypeptides encoding baboon tafi
|
CN101006177B
(zh)
|
2002-03-15 |
2011-10-12 |
纽韦卢森公司 |
改善的用于合成模制分子的方法
|
US7544767B2
(en)
|
2002-04-05 |
2009-06-09 |
Burnham Institute For Medical Research |
HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
|
CA2482856A1
(en)
|
2002-04-15 |
2003-10-30 |
American National Red Cross |
Plasma protein-binding ligands
|
US20060275753A1
(en)
*
|
2002-04-15 |
2006-12-07 |
Hammond David J |
Recovery of analytes using combinatorial libraries
|
JP2006506058A
(ja)
*
|
2002-05-17 |
2006-02-23 |
アルフレッド イー. スラネッズ, |
標的機能を決定して薬物リードを同定するためのプロセス
|
US7893218B2
(en)
|
2003-06-16 |
2011-02-22 |
Stowers Institute For Medical Research |
Antibodies that specifically bind SOST peptides
|
WO2004001010A2
(en)
*
|
2002-06-21 |
2003-12-31 |
Ptc Therapeutics, Inc. |
METHODS FOR IDENTIFYING SMALL MOLECULES THAT MODULATE PREMATURE TRANSLATION TERMINATION AND NONSENSE MEDIATED mRNA DECAY
|
US20100168037A1
(en)
*
|
2002-07-03 |
2010-07-01 |
Bio Science International, Inc. |
Peptides comprising aromatic d-amino acids and methods of use
|
JP4486497B2
(ja)
*
|
2002-07-11 |
2010-06-23 |
アメリカン ナショナル レッド クロス |
複合混合物中の個々の活性成分を同定する方法
|
US7301006B2
(en)
*
|
2002-07-16 |
2007-11-27 |
Wisconsin Alumni Research Foundation |
Methods and materials for the synthesis of modified peptides
|
US7927791B2
(en)
*
|
2002-07-24 |
2011-04-19 |
Ptc Therapeutics, Inc. |
Methods for identifying small molecules that modulate premature translation termination and nonsense mediated mRNA decay
|
US10730906B2
(en)
|
2002-08-01 |
2020-08-04 |
Nuevolutions A/S |
Multi-step synthesis of templated molecules
|
WO2004016733A2
(en)
|
2002-08-16 |
2004-02-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
MX367615B
(es)
|
2002-09-06 |
2019-08-28 |
Cerulean Pharma Inc |
Polimeros a base de ciclodextrina para el suministro de agentes terapeuticos.
|
US7157228B2
(en)
*
|
2002-09-09 |
2007-01-02 |
Bioarray Solutions Ltd. |
Genetic analysis and authentication
|
US20050064508A1
(en)
|
2003-09-22 |
2005-03-24 |
Semzyme |
Peptide mediated synthesis of metallic and magnetic materials
|
EP1572978A4
(en)
*
|
2002-10-16 |
2006-05-24 |
Univ Texas |
COMBINATORIAL BANKS OF APTAMERS WITH OLIGONUCLEOTIDE OLIGONUCLEOTIDE PHOSPHOROTHIOATE AND PHOSPHORODITHIOATE GROUPS RELATED TO BALLS
|
AU2003272169A1
(en)
*
|
2002-10-24 |
2004-05-13 |
Biacore Ab |
Assay with co-immobilized ligands
|
ES2640279T3
(es)
|
2002-10-30 |
2017-11-02 |
Nuevolution A/S |
Procedimiento para la síntesis de un complejo bifuncional
|
WO2004047007A1
(en)
|
2002-11-15 |
2004-06-03 |
Bioarray Solutions, Ltd. |
Analysis, secure access to, and transmission of array images
|
EP2317317B1
(en)
|
2002-12-03 |
2014-11-26 |
North Carolina State University |
Prion protein ligands and methods of use
|
US20040185473A1
(en)
*
|
2002-12-17 |
2004-09-23 |
Affymetrix, Inc. |
Releasable polymer arrays
|
US9121110B2
(en)
|
2002-12-19 |
2015-09-01 |
Nuevolution A/S |
Quasirandom structure and function guided synthesis methods
|
US7736909B2
(en)
*
|
2003-01-09 |
2010-06-15 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising capture agents
|
AT413945B
(de)
*
|
2003-01-14 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff für die alzheimer-krankheit
|
WO2004074429A2
(en)
|
2003-02-21 |
2004-09-02 |
Nuevolution A/S |
Method for producing second-generation library
|
GB0305448D0
(en)
*
|
2003-03-10 |
2003-04-16 |
Tcp Innovations Ltd |
Immunoassay
|
US20040185499A1
(en)
*
|
2003-03-20 |
2004-09-23 |
Jolley Michael E. |
Method of epitope scanning using fluorescence polarization
|
US20040235054A1
(en)
*
|
2003-03-28 |
2004-11-25 |
The Regents Of The University Of California |
Novel encoding method for "one-bead one-compound" combinatorial libraries
|
US20040235053A1
(en)
*
|
2003-03-28 |
2004-11-25 |
The Regents Of The University Of California |
Preparation and application of encoded bead aggregates in combinatorial chemistry
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
GB0307428D0
(en)
*
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
US20040235027A1
(en)
*
|
2003-03-31 |
2004-11-25 |
Regent Of The University Of California |
Preparation and application of ligand-biopolymer conjugates
|
GB0307403D0
(en)
*
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
PL1615992T3
(pl)
|
2003-04-04 |
2014-03-31 |
Pathogen Removal And Diagnostic Tech Inc |
Materiały wiążące białko prionowe i sposoby ich zastosowania
|
US7510848B2
(en)
|
2003-04-04 |
2009-03-31 |
North Carolina State University |
Prion protein binding materials and methods of use
|
US20040210036A1
(en)
*
|
2003-04-15 |
2004-10-21 |
Nanogen, Inc. |
Peptide substrate libraries
|
EP1641555B1
(en)
|
2003-04-30 |
2020-12-02 |
Nexus Biosystems, Inc. |
Multi-well plate providing a high-density storage and assay platform
|
CA2526691A1
(en)
*
|
2003-05-23 |
2005-04-28 |
Board Of Regents - The University Of Texas System |
High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens
|
EP1635765B1
(en)
*
|
2003-05-23 |
2013-07-17 |
Board Of Regents, The University Of Texas System |
Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
|
CN101090729B
(zh)
|
2003-05-30 |
2014-07-23 |
艾更斯司股份有限公司 |
前列腺干细胞抗原(psca)变体及其序列
|
EP1631799A2
(en)
*
|
2003-06-06 |
2006-03-08 |
Combinatorx Incorporated |
System and method for multidimensional evaluation of combinations of compositions
|
US7672791B2
(en)
*
|
2003-06-13 |
2010-03-02 |
International Business Machines Corporation |
Method of performing three-dimensional molecular superposition and similarity searches in databases of flexible molecules
|
EP1648909A4
(en)
*
|
2003-07-24 |
2008-11-12 |
Univ Texas |
THIOAPTAMERS FOR DISCOVERING PHYSIOLOGICAL PATHWAYS AND NEW THERAPEUTIC STRATEGIES
|
WO2005041684A2
(en)
|
2003-08-06 |
2005-05-12 |
Senomyx Inc. |
Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
|
US7927796B2
(en)
|
2003-09-18 |
2011-04-19 |
Bioarray Solutions, Ltd. |
Number coding for identification of subtypes of coded types of solid phase carriers
|
DE602004023960D1
(de)
|
2003-09-18 |
2009-12-17 |
Nuevolution As |
Methode zur Gewinnung struktureller Informationen kodierter Moleküle und zur Selektion von Verbindungen
|
EP1664722B1
(en)
|
2003-09-22 |
2011-11-02 |
Bioarray Solutions Ltd |
Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
|
WO2005035552A2
(en)
*
|
2003-10-07 |
2005-04-21 |
Genzyme Corporation |
Transducing combinatorial peptide library
|
US7563569B2
(en)
|
2003-10-28 |
2009-07-21 |
Michael Seul |
Optimization of gene expression analysis using immobilized capture probes
|
JP2007509629A
(ja)
|
2003-10-29 |
2007-04-19 |
バイオアレイ ソリューションズ リミテッド |
二本鎖dnaの切断による複合核酸分析
|
EP2369348A1
(en)
|
2003-11-07 |
2011-09-28 |
Ciphergen Biosystems, Inc. |
Biomarkers for Alzheimer's disease
|
US8071839B2
(en)
|
2003-12-24 |
2011-12-06 |
G2 Inflammation Pty Ltd |
Transgenic mouse comprising a polynucleotide encoding human or humanized C5aR and methods of production and use
|
US20050164167A1
(en)
*
|
2004-01-28 |
2005-07-28 |
Buscher Benjamin A. |
Method of discovery and development of broad-spectrum antiviral drugs
|
US20050221339A1
(en)
*
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
RS52918B
(en)
|
2004-04-02 |
2014-02-28 |
The Regents Of The University Of California |
PROCEDURES AND MIXTURES FOR TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH ALFA V BETA 5 INTEGRINE
|
US7794713B2
(en)
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
RU2418633C2
(ru)
|
2004-04-08 |
2011-05-20 |
Байоматрика, Инк. |
Объединение процессов хранения образцов и управление образцами в медико-биологических науках
|
US20050239134A1
(en)
*
|
2004-04-21 |
2005-10-27 |
Board Of Regents, The University Of Texas System |
Combinatorial selection of phosphorothioate single-stranded DNA aptamers for TGF-beta-1 protein
|
US7939251B2
(en)
|
2004-05-06 |
2011-05-10 |
Roche Molecular Systems, Inc. |
SENP1 as a marker for cancer
|
DE602005015715D1
(de)
|
2004-05-25 |
2009-09-10 |
2Curex A P S |
Identifizierung von eine zelluläre antwort modifizierenden verbindungen
|
PL1753871T3
(pl)
|
2004-05-28 |
2016-01-29 |
Agensys Inc |
Przeciwciała i powiązane cząsteczki, które wiążą się z antygenem komórek macierzystych prostaty (PSCA)
|
ATE551432T1
(de)
|
2004-06-21 |
2012-04-15 |
Univ Leland Stanford Junior |
Bei manisch-depressiver erkrankung und/oder schwerer depressiver erkrankung unterschiedlich exprimierte gene und wege
|
JP4507080B2
(ja)
*
|
2004-07-30 |
2010-07-21 |
東亞合成株式会社 |
抗菌ペプチド及びその利用
|
US7848889B2
(en)
|
2004-08-02 |
2010-12-07 |
Bioarray Solutions, Ltd. |
Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
|
EP2633858A3
(en)
|
2004-08-20 |
2013-12-11 |
Buck Institute for Age Research |
Small molecules that replace or agonize p53 function
|
US7968287B2
(en)
*
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
US7850960B2
(en)
|
2004-12-30 |
2010-12-14 |
University Of Washington |
Methods for regulation of stem cells
|
US8338093B2
(en)
*
|
2004-12-31 |
2012-12-25 |
Affymetrix, Inc. |
Primer array synthesis and validation
|
US7547775B2
(en)
|
2004-12-31 |
2009-06-16 |
Affymetrix, Inc. |
Parallel preparation of high fidelity probes in an array format
|
WO2006084130A2
(en)
*
|
2005-02-03 |
2006-08-10 |
Perkinelmer Las, Inc. |
Ultra-sensitive detection systems using multidimension signals
|
US20100196509A1
(en)
|
2005-02-28 |
2010-08-05 |
Jonathan Braun |
Methods for Diagnosis and Treatment of Endometrial Cancer
|
US20100240770A1
(en)
*
|
2005-03-11 |
2010-09-23 |
Jifa Qi |
Synthesis and use of colloidal III-V nanoparticles
|
EP1863531A1
(en)
|
2005-03-19 |
2007-12-12 |
Medical Research Council |
Improvements in or relating to treatment and prevention of viral infections
|
EP1866328B1
(en)
|
2005-03-22 |
2011-01-12 |
Rohto Pharmaceutical Co., Ltd. |
Peptides which increase collagen or hyaluronic acid production
|
JP4841618B2
(ja)
|
2005-03-23 |
2011-12-21 |
バイオ−ラッド ラボラトリーズ インコーポレーティッド |
タンパク質を精製するための方法
|
EP2444099A1
(en)
|
2005-03-31 |
2012-04-25 |
Agensys, Inc. |
Antibodies and related molecules that bind to 161P2F10B proteins
|
US8318906B2
(en)
|
2005-04-15 |
2012-11-27 |
The Regents Of The University Of California |
EMP2 antibodies and their therapeutic uses
|
US20070099830A1
(en)
|
2005-04-21 |
2007-05-03 |
Massachusetts Institute Of Technology |
Sirt4 activities
|
WO2006124644A2
(en)
*
|
2005-05-12 |
2006-11-23 |
Board Of Regents, The University Of Texas System |
Protein and antibody profiling using small molecule microarrays
|
US8486629B2
(en)
|
2005-06-01 |
2013-07-16 |
Bioarray Solutions, Ltd. |
Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
ES2710601T3
(es)
|
2005-07-19 |
2019-04-26 |
Stemgen S P A |
Inhibición del potencial tumorigénico de células madre tumorales por LIF
|
JP2009507472A
(ja)
*
|
2005-08-16 |
2009-02-26 |
ザ チルドレンズ マーシー ホスピタル |
マイクロスフェア懸濁ハイブリダイゼーションの定量化およびその用途
|
US7943134B2
(en)
|
2005-08-31 |
2011-05-17 |
Academia Sinica |
Compositions and methods for identifying response targets and treating flavivirus infection responses
|
US7781209B2
(en)
|
2005-09-25 |
2010-08-24 |
Multispan, Inc. |
GPCR-expressing cell lines
|
EP1937718B1
(en)
|
2005-10-20 |
2017-12-06 |
Senomyx, Inc. |
Chimeric human sweet-umami and umami-sweet taste receptors
|
US8119572B2
(en)
*
|
2005-10-24 |
2012-02-21 |
Wisconsin Alumni Research Foundation |
Methods for determining protein binding specificity using peptide libraries
|
AU2006311827A1
(en)
|
2005-11-03 |
2007-05-18 |
Redpoint Bio Corporation |
High throughput screening assay for the TRPM5 ion channel
|
WO2007056352A2
(en)
|
2005-11-07 |
2007-05-18 |
The Scripps Research Institute |
Compositions and methods for controlling tissue factor signaling specificity
|
AU2006315562C1
(en)
|
2005-11-12 |
2013-10-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for treating depression using NCAM peptide mimetics
|
US7576037B2
(en)
|
2005-11-18 |
2009-08-18 |
Mei Technologies, Inc. |
Process and apparatus for combinatorial synthesis
|
SI2341140T1
(sl)
|
2005-12-01 |
2017-12-29 |
Nuevolution A/S |
Postopki encimskega kodiranja za učinkovito sintezo velikih knjižnic
|
GB2433506A
(en)
*
|
2005-12-20 |
2007-06-27 |
Sharp Kk |
A method of producing a multimeric capture agent
|
GB2433505A
(en)
*
|
2005-12-20 |
2007-06-27 |
Sharp Kk |
Capture agents for binding a ligand
|
GB2433591A
(en)
*
|
2005-12-20 |
2007-06-27 |
Sharp Kk |
Method for functionalising a hydrophobic substrate
|
EP1976567B1
(en)
|
2005-12-28 |
2020-05-13 |
The Scripps Research Institute |
Natural antisense and non-coding rna transcripts as drug targets
|
CA2636855C
(en)
*
|
2006-01-11 |
2016-09-27 |
Raindance Technologies, Inc. |
Microfluidic devices and methods of use in the formation and control of nanoreactors
|
WO2007079755A1
(en)
*
|
2006-01-12 |
2007-07-19 |
Janus Beierholm Holding Aps |
Reimmunization and antibody design
|
US20070186296A1
(en)
*
|
2006-02-02 |
2007-08-09 |
Wyeth |
Cloning, characterization, and application of tnfrsf19 in neurological disorders
|
US20100278821A1
(en)
|
2006-03-21 |
2010-11-04 |
The Regents Of The University Of California |
N-cadherin: target for cancer diagnosis and therapy
|
EP2390666A1
(en)
|
2006-03-21 |
2011-11-30 |
The Regents of The University of California |
N-Cadherin as target for cancer diagnosis and therapy
|
BRPI0710482A2
(pt)
*
|
2006-04-21 |
2011-08-16 |
Wyeth Corp |
métodos para seleção de alto rendimento de linhagens celulares
|
ES2640453T3
(es)
|
2006-04-21 |
2017-11-03 |
Senomyx, Inc. |
Procesos para preparar composiciones saborizantes sólidas
|
CN101421419B
(zh)
|
2006-05-02 |
2012-08-29 |
学校法人帝京大学 |
增加谷胱甘肽的物质的筛选方法
|
WO2007124755A1
(en)
|
2006-05-02 |
2007-11-08 |
The Antibody Project Aps |
Method for immunizing an avian species
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
EP3031918B1
(en)
*
|
2006-05-11 |
2018-03-14 |
Raindance Technologies Inc. |
Microfluidic devices
|
US7862812B2
(en)
|
2006-05-31 |
2011-01-04 |
Lpath, Inc. |
Methods for decreasing immune response and treating immune conditions
|
DE602006012460D1
(de)
|
2006-06-07 |
2010-04-08 |
Nutrinova Gmbh |
Verfahren zum Screening von Substanzen die die Aktivität von Gpcrs modulieren
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
WO2008013861A2
(en)
|
2006-07-27 |
2008-01-31 |
Redpoint Bio Corporation |
Screening assay for inhibitors of trpa1 activation by a lower alkyl phenol
|
WO2008021123A1
(en)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Fluorocarbon emulsion stabilizing surfactants
|
EP2423332A1
(en)
|
2006-08-25 |
2012-02-29 |
Oncotherapy Science, Inc. |
Prognostic markers and therapeutic targets for lung cancer
|
AU2007292219B2
(en)
|
2006-09-06 |
2014-04-24 |
The Regents Of The University Of California |
Molecular diagnosis and classification of malignant melanoma
|
US20090252745A1
(en)
*
|
2006-09-15 |
2009-10-08 |
Duke University |
Amino acids in the HCV core polypeptide domain 3 and correlation with steatosis
|
CA2669084A1
(en)
|
2006-11-10 |
2008-05-29 |
Massachusetts Institute Of Technology |
Pak modulators
|
WO2008067196A2
(en)
|
2006-11-16 |
2008-06-05 |
The Regents Of The University Of California |
Methods for identifying inhibitors of solute transporters
|
EP2114396A4
(en)
|
2006-12-29 |
2010-03-10 |
Salk Inst For Biological Studi |
METHOD FOR IMPROVING TRAINING PERFORMANCE
|
JP2010516625A
(ja)
|
2007-01-24 |
2010-05-20 |
インサート セラピューティクス, インコーポレイテッド |
制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
|
WO2008097559A2
(en)
|
2007-02-06 |
2008-08-14 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
WO2008130623A1
(en)
|
2007-04-19 |
2008-10-30 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
US20080269065A1
(en)
*
|
2007-04-30 |
2008-10-30 |
Syntrix Biosystems, Inc. |
Conformationally Constrained Analytical Probes
|
KR101440153B1
(ko)
*
|
2007-05-09 |
2014-09-15 |
재단법인서울대학교산학협력재단 |
펩타이드 라이브러리를 이용한 단백질 인산화 효소의기질특이성 분석 방법
|
EP2581081A3
(en)
|
2007-06-01 |
2013-07-31 |
The Trustees Of Princeton University |
Treatment of viral infections by modulation of host cell metabolic pathways
|
CN101873858B
(zh)
*
|
2007-06-11 |
2016-05-25 |
R·骆克·麦克唐纳 |
用于预防脑血管痉挛的药物递送系统
|
US10092524B2
(en)
|
2008-06-11 |
2018-10-09 |
Edge Therapeutics, Inc. |
Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage
|
US8334239B2
(en)
*
|
2007-07-10 |
2012-12-18 |
The Board Of Regents Of The University Of Texas System |
High affinity VEGF-receptor antagonists
|
WO2009021077A2
(en)
*
|
2007-08-06 |
2009-02-12 |
THE GOVERMENT OF THE UNITED STATES OF AMERICA. as represented by THE SECRETARY OF THE NAVY |
Beta helical peptide structures stable in aqueous and non-aqueous media and methods for preparing same
|
US8703161B2
(en)
*
|
2007-08-13 |
2014-04-22 |
Elc Management, Llc |
Skin repair compositions comprising circadian gene activators and a synergistic combination of Sirt1 gene activators
|
ES2477294T3
(es)
|
2007-08-13 |
2014-07-16 |
Baxter International Inc |
Modulación por IVIG de quimioquinas para el tratamiento de la esclerosis múltiple, la enfermedad de Alzheimer y la enfermedad de Parkinson
|
WO2009025793A2
(en)
|
2007-08-21 |
2009-02-26 |
Senomyx, Inc. |
Human t2r bitterness receptors and uses thereof
|
CA2702025A1
(en)
|
2007-10-01 |
2009-04-09 |
Redpoint Bio Corporation |
A non-desensitizing mutant of the transient receptor potential trpm5 ion channel
|
ES2629440T5
(es)
|
2007-10-04 |
2020-11-20 |
Zymogenetics Inc |
zB7H6 miembro de la familia B7 y composiciones y métodos relacionados
|
EP2924435A3
(en)
|
2007-10-22 |
2015-11-04 |
The Regents of The University of California |
Biomarkers for prenatal diagnosis of congenital cytomegalovirus
|
CA2703519C
(en)
|
2007-11-09 |
2017-04-18 |
The Salk Institute For Biological Studies |
Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
|
WO2009079373A2
(en)
|
2007-12-14 |
2009-06-25 |
The Regents Of The University Of California |
Inhibitors of calcium-activated chloride channels
|
US9187535B2
(en)
|
2007-12-19 |
2015-11-17 |
Affibody Ab |
Polypeptide derived from protein A and able to bind PDGF
|
EP2077272A1
(en)
*
|
2007-12-21 |
2009-07-08 |
Affibody AB |
Polypeptide libraries with a predetermined scaffold
|
EP2072525A1
(en)
|
2007-12-21 |
2009-06-24 |
Affibody AB |
New polypeptides having affinity for HER2
|
CA2716357A1
(en)
|
2008-03-05 |
2009-09-11 |
The Regents Of The University Of California |
Molecular diagnosis and classification of malignant melanoma
|
AU2009225665B9
(en)
|
2008-03-17 |
2015-01-15 |
The Scripps Research Institute |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
WO2009131957A2
(en)
|
2008-04-21 |
2009-10-29 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising oxadiazole derivatives
|
ES2613844T3
(es)
|
2008-04-21 |
2017-05-26 |
Lawrence Livermore National Security, Llc |
Ligandos polidentados de alta afinidad selectivos y métodos para producirlos
|
JP2010043063A
(ja)
|
2008-05-09 |
2010-02-25 |
Agency For Science Technology & Research |
川崎病の診断及び治療
|
AU2009266924B2
(en)
*
|
2008-07-01 |
2015-12-10 |
Genocea Biosciences, Inc. |
Antigen screening system
|
EP2315629B1
(en)
|
2008-07-18 |
2021-12-15 |
Bio-Rad Laboratories, Inc. |
Droplet libraries
|
CA2735710A1
(en)
|
2008-08-04 |
2010-02-11 |
Glen N. Barber |
Sting (stimulator of interferon genes), a regulator of innate immune responses
|
CA2733790A1
(en)
|
2008-08-20 |
2010-02-25 |
Ensemble Discovery Corporation |
Macrocyclic compounds for inhibition of tumor necrosis factor alpha
|
WO2010039536A2
(en)
|
2008-09-23 |
2010-04-08 |
President And Fellows Of Harvard College |
Sirt4 and uses thereof
|
WO2010036866A1
(en)
|
2008-09-25 |
2010-04-01 |
University Of Guelph |
Nitrogen responsive early nodulin gene
|
WO2010047515A2
(ko)
|
2008-10-20 |
2010-04-29 |
광주과학기술원 |
바이포달 펩타이드 바인더
|
EP3260123A1
(en)
|
2008-11-06 |
2017-12-27 |
University of Miami |
Role of soluble upar in the pathogenesis of proteinuric kidney disease
|
EP2352847B1
(en)
|
2008-11-10 |
2014-01-08 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Gene signature for predicting prognosis of patients with solid tumors
|
EP2370450A1
(en)
|
2008-11-27 |
2011-10-05 |
Roche Diagnostics GmbH |
Directed synthesis of oligophosphoramidate stereoisomers
|
CN105001196B
(zh)
|
2008-12-03 |
2017-05-10 |
斯克里普斯研究所 |
干细胞培养
|
KR101829469B1
(ko)
|
2008-12-04 |
2018-03-30 |
큐알엔에이, 인크. |
Epo에 대한 천연 안티센스 전사체의 억제에 의해 에리트로포에틴(epo) 관련된 질환의 치료
|
MX2011005912A
(es)
|
2008-12-04 |
2011-06-17 |
Opko Curna Llc |
Tratamiento de enfermedades relacionadas con factor de crecimiento endotelial vascular por inhibicion de transcrito antisentido natural para factor de crecimiento endotelial vascular.
|
KR101866152B1
(ko)
|
2008-12-04 |
2018-06-08 |
큐알엔에이, 인크. |
종양 억제 유전자에 대한 천연 안티센스 전사체의 억제에 의해 종양 억제 유전자 관련된 질환의 치료
|
EP2370175A2
(en)
|
2008-12-16 |
2011-10-05 |
Bristol-Myers Squibb Company |
Methods of inhibiting quiescent tumor proliferation
|
CN102317442B
(zh)
|
2008-12-17 |
2014-08-13 |
斯克里普斯研究所 |
干细胞的产生和保持
|
US20120165650A1
(en)
|
2010-12-22 |
2012-06-28 |
General Electric Company |
Her2 binders
|
CN101768213B
(zh)
|
2008-12-30 |
2012-05-30 |
中国科学院遗传与发育生物学研究所 |
一种与植物分蘖数目相关的蛋白及其编码基因与应用
|
CA2752237C
(en)
|
2009-02-12 |
2020-03-24 |
Opko Curna, Llc |
Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
|
CN101817879A
(zh)
|
2009-02-26 |
2010-09-01 |
中国科学院遗传与发育生物学研究所 |
金属硫蛋白及其编码基因与应用
|
US9464287B2
(en)
|
2009-03-16 |
2016-10-11 |
Curna, Inc. |
Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
|
WO2010107740A2
(en)
|
2009-03-17 |
2010-09-23 |
Curna, Inc. |
Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1
|
WO2010111231A1
(en)
|
2009-03-23 |
2010-09-30 |
Raindance Technologies, Inc. |
Manipulation of microfluidic droplets
|
BRPI1014121A2
(pt)
|
2009-03-27 |
2016-11-08 |
Gojo Ind Inc |
composições e métodos para investigação e uso de compostos que antagonizam as interações esporo-superfície
|
US8343976B2
(en)
|
2009-04-20 |
2013-01-01 |
Institute For Oneworld Health |
Compounds, compositions and methods comprising pyrazole derivatives
|
KR101722541B1
(ko)
|
2009-05-06 |
2017-04-04 |
큐알엔에이, 인크. |
Ttp에 대한 천연 안티센스 전사체의 억제에 의한 트리스테트라프롤린 관련된 질환의 치료
|
US9155754B2
(en)
|
2009-05-06 |
2015-10-13 |
Curna, Inc. |
Treatment of ABCA1 gene related diseases by inhibition of a natural antisense transcript to ABCA1
|
JP5931720B2
(ja)
|
2009-05-08 |
2016-06-08 |
クルナ・インコーポレーテッド |
Dmdファミリーに対する天然アンチセンス転写物の抑制によるジストロフィンファミリー関連疾患の治療
|
DK2432881T3
(en)
|
2009-05-18 |
2018-02-26 |
Curna Inc |
TREATMENT OF REPROGRAMMING FACTOR-RELATED DISEASES BY INHIBITING NATURAL ANTISENSE TRANSCRIPTS TO A REPROGRAMMING FACTOR
|
EP2432882B1
(en)
|
2009-05-22 |
2019-12-25 |
CuRNA, Inc. |
TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3
|
WO2010138806A2
(en)
|
2009-05-28 |
2010-12-02 |
Curna, Inc. |
Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
|
CN102612560B
(zh)
|
2009-06-16 |
2017-10-17 |
库尔纳公司 |
通过抑制针对对氧磷酶1(pon1)的天然反义转录物来治疗pon1相关的疾病
|
US20120171170A1
(en)
|
2009-06-16 |
2012-07-05 |
Opko Curna, Llc |
Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
|
JP6073133B2
(ja)
|
2009-06-24 |
2017-02-01 |
クルナ・インコーポレーテッド |
腫瘍壊死因子受容体2(tnfr2)に対する天然アンチセンス転写物の抑制によるtnfr2関連疾患の治療
|
WO2010151674A2
(en)
|
2009-06-26 |
2010-12-29 |
Curna, Inc. |
Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
|
US20120122711A1
(en)
*
|
2009-07-15 |
2012-05-17 |
Heath James R |
Screening of biopolymers
|
WO2011008173A1
(en)
*
|
2009-07-15 |
2011-01-20 |
Agency For Science, Technology And Research |
Improved screening of biopolymers
|
US9863956B2
(en)
|
2009-07-22 |
2018-01-09 |
Agency For Science, Technology And Research |
Differentiation of isobaric amino acids and other species
|
US10087252B2
(en)
|
2009-07-24 |
2018-10-02 |
The Regents Of The University Of California |
Methods and compositions for treating and preventing disease associated with αvβ5 integrin
|
WO2011011700A2
(en)
|
2009-07-24 |
2011-01-27 |
Curna, Inc. |
Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
|
ES2585360T3
(es)
|
2009-08-05 |
2016-10-05 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con un gen de la insulina (INS) por inhibición de la transcripción antisentido natural en un gen de la insulina (INS)
|
ES2599986T3
(es)
|
2009-08-11 |
2017-02-06 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con adiponectina (ADIPOQ) mediante la inhibición de un transcrito antisentido natural de una adiponectina (ADIPOQ)
|
MX2012001746A
(es)
|
2009-08-14 |
2012-03-21 |
Univ California |
Metodos de diagnostico y tratamiento de autismo.
|
WO2011022638A1
(en)
|
2009-08-20 |
2011-02-24 |
Transposagen Biopharmaceuticals, Inc. |
Trp inhibitors and uses thereof
|
WO2011022606A2
(en)
|
2009-08-21 |
2011-02-24 |
Curna, Inc. |
Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
|
EP2470566A1
(en)
|
2009-08-24 |
2012-07-04 |
St. Jude Children's Research Hospital |
Compositions and methods for potentiating interleukin-35
|
KR101892760B1
(ko)
|
2009-08-25 |
2018-08-28 |
큐알엔에이, 인크. |
IQGAP에 대한 천연 안티센스 전사체의 억제에 의한 GTPase 활성화 단백질을 함유하는 IQ 모티프(IQGAP)와 관련된 질환의 치료
|
WO2011038210A2
(en)
|
2009-09-25 |
2011-03-31 |
Curna, Inc. |
Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
|
US10520500B2
(en)
|
2009-10-09 |
2019-12-31 |
Abdeslam El Harrak |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
ES2365343B1
(es)
|
2009-11-19 |
2012-07-10 |
Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii |
Uso de cd98 como marcador de receptividad endometrial.
|
EP2501409A4
(en)
|
2009-11-20 |
2015-02-18 |
Univ California |
EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) AND PROLIFERATIVE VITREORETINOPATHY (PVR)
|
CN102781237A
(zh)
*
|
2009-11-23 |
2012-11-14 |
天蓝制药公司 |
用于传递治疗剂的基于环糊精的聚合物
|
RU2639550C2
(ru)
|
2009-12-16 |
2017-12-21 |
Курна, Инк. |
Лечение заболеваний, связанных с сайт-1 мембраносвязанной пептидазой транскрипционных факторов (mbtps1), путем ингибирования природного антисмыслового транскрипта к mbtps1
|
EP2517025B1
(en)
|
2009-12-23 |
2019-11-27 |
Bio-Rad Laboratories, Inc. |
Methods for reducing the exchange of molecules between droplets
|
WO2011079263A2
(en)
|
2009-12-23 |
2011-06-30 |
Curna, Inc. |
Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
|
WO2011079261A2
(en)
|
2009-12-23 |
2011-06-30 |
Curna, Inc. |
Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
|
WO2011090741A2
(en)
|
2009-12-29 |
2011-07-28 |
Opko Curna, Llc |
TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63
|
ES2657452T3
(es)
|
2009-12-29 |
2018-03-05 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con el factor respiratorio nuclear 1 (NRF1) mediante inhibición de transcrito antisentido natural a NRF1
|
DK2519632T3
(en)
|
2009-12-31 |
2018-07-23 |
Curna Inc |
TREATMENT OF INSULIN RECEPTOR SUBSTRATE 2- (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPTION TO IRS2 AND TRANSCRIPTION FACTOR E3 (TFE3)
|
WO2011082409A2
(en)
|
2010-01-04 |
2011-07-07 |
Curna, Inc. |
Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
|
KR101853509B1
(ko)
|
2010-01-06 |
2018-04-30 |
큐알엔에이, 인크. |
췌장 발달 유전자에 대한 천연 안티센스 전사체의 억제에 의한 췌장 발달 유전자와 관련된 질환의 치료
|
ES2664866T3
(es)
|
2010-01-11 |
2018-04-23 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con la globulina fijadora de hormonas sexuales (shbg) mediante inhibición del transcrito antisentido natural a shbg
|
US9073033B2
(en)
|
2010-01-19 |
2015-07-07 |
Illumina, Inc. |
Methods and compositions for processing chemical reactions
|
WO2011091435A2
(en)
|
2010-01-25 |
2011-07-28 |
Mount Sinai School Of Medicine |
Methods of treating liver disease
|
WO2011091390A2
(en)
|
2010-01-25 |
2011-07-28 |
Opko Curna, Llc |
Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
|
WO2011094759A2
(en)
|
2010-02-01 |
2011-08-04 |
The Regents Of The University Of California |
Novel diagnostic and therapeutic targets associated with or regulated by n-cadherin expression and/or epithelial to mesenchymal transition (emt) in prostate cancer and other malignancies
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
CA2789425C
(en)
|
2010-02-12 |
2020-04-28 |
Raindance Technologies, Inc. |
Digital analyte analysis with polymerase error correction
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US8962586B2
(en)
|
2010-02-22 |
2015-02-24 |
Curna, Inc. |
Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related diseases by inhibition of natural antisense transcript to PYCR1
|
TWI600759B
(zh)
|
2010-04-02 |
2017-10-01 |
可娜公司 |
藉由抑制群落刺激因子3(csf3)之天然反義轉錄物以治療csf3相關疾病
|
JP5978203B2
(ja)
|
2010-04-09 |
2016-08-24 |
カッパーアールエヌエー,インコーポレイテッド |
Fgf21に対する天然アンチセンス転写物の阻害による線維芽細胞増殖因子(fgf21)線維芽細胞増殖因子fgf21)関連疾患の治療
|
LT2558577T
(lt)
|
2010-04-16 |
2019-03-12 |
Nuevolution A/S |
Bifunkciniai kompleksai ir tokių kompleksų gamybos ir naudojimo būdai
|
RU2018110642A
(ru)
|
2010-05-03 |
2019-02-27 |
Курна, Инк. |
Лечение заболеваний, связанных с сиртуином (sirt), путем ингибирования природного антисмыслового транскрипта к сиртуину (sirt)
|
TWI531370B
(zh)
|
2010-05-14 |
2016-05-01 |
可娜公司 |
藉由抑制par4天然反股轉錄本治療par4相關疾病
|
EP3299464B1
(en)
|
2010-05-26 |
2019-10-02 |
CuRNA, Inc. |
Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1
|
NO2576784T3
(fi)
|
2010-05-26 |
2018-04-14 |
|
|
EP2400304A1
(en)
|
2010-06-22 |
2011-12-28 |
Centro de Investigación Cooperativa En Biomateriales ( CIC biomaGUNE) |
Method for the characterization of intermolecular interactions
|
JP6023705B2
(ja)
|
2010-06-23 |
2016-11-09 |
カッパーアールエヌエー,インコーポレイテッド |
ナトリウムチャネル、電位依存性、αサブユニット(SCNA)に対する天然アンチセンス転写物の阻害によるSCNA関連疾患の治療
|
CN103068982B
(zh)
|
2010-07-14 |
2017-06-09 |
库尔纳公司 |
通过抑制盘状大同系物(dlg)的天然反义转录物而治疗dlg相关疾病
|
WO2012018638A2
(en)
|
2010-07-26 |
2012-02-09 |
Biomatrica, Inc. |
Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
|
US9845489B2
(en)
|
2010-07-26 |
2017-12-19 |
Biomatrica, Inc. |
Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
|
SG188314A1
(en)
*
|
2010-08-27 |
2013-04-30 |
Agency Science Tech & Res |
Peptide libraries for screening and other applications
|
US9562897B2
(en)
|
2010-09-30 |
2017-02-07 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
EP2625274B1
(en)
|
2010-10-06 |
2017-07-19 |
CuRNA, Inc. |
Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
|
WO2012052391A1
(en)
|
2010-10-19 |
2012-04-26 |
Glaxo Group Limited |
Polypeptide with jmjd3 catalytic activity
|
JP6049623B2
(ja)
|
2010-10-22 |
2016-12-21 |
カッパーアールエヌエー,インコーポレイテッド |
α‐L‐イズロニダーゼ(IDUA)への天然アンチセンス転写物の阻害によるIDUA関連疾患の治療
|
US10000752B2
(en)
|
2010-11-18 |
2018-06-19 |
Curna, Inc. |
Antagonat compositions and methods of use
|
WO2012074855A2
(en)
|
2010-11-22 |
2012-06-07 |
The Regents Of The University Of California |
Methods of identifying a cellular nascent rna transcript
|
JP6071893B2
(ja)
|
2010-11-23 |
2017-02-01 |
カッパーアールエヌエー,インコーポレイテッド |
Nanogへの天然アンチセンス転写物の阻害によるnanog関連疾患の治療
|
CN103380212B
(zh)
|
2010-12-22 |
2017-04-05 |
菲特治疗公司 |
用于单细胞分选与增强ipsc重新编程的细胞培养平台
|
WO2012109495A1
(en)
|
2011-02-09 |
2012-08-16 |
Metabolic Solutions Development Company, Llc |
Cellular targets of thiazolidinediones
|
EP2673614B1
(en)
|
2011-02-11 |
2018-08-01 |
Raindance Technologies, Inc. |
Method for forming mixed droplets
|
US9150852B2
(en)
|
2011-02-18 |
2015-10-06 |
Raindance Technologies, Inc. |
Compositions and methods for molecular labeling
|
EP3502236B1
(en)
|
2011-02-18 |
2023-08-23 |
The Scripps Research Institute |
Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
|
WO2012119989A2
(en)
|
2011-03-04 |
2012-09-13 |
Oryzon Genomics, S.A. |
Methods and antibodies for the diagnosis and treatment of cancer
|
JP6189754B2
(ja)
|
2011-03-04 |
2017-08-30 |
イントレキソン コーポレーション |
タンパク質を条件的に発現するベクター
|
SG193991A1
(en)
|
2011-04-05 |
2013-11-29 |
Edge Therapeutics |
Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow
|
US20120301904A1
(en)
|
2011-04-26 |
2012-11-29 |
Prosetta Antiviral, Inc |
Multiprotein assemblies
|
EP2710144B1
(en)
|
2011-05-19 |
2020-10-07 |
Agena Bioscience, Inc. |
Processes for multiplex nucleic acid identification
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
EP2714970B1
(en)
|
2011-06-02 |
2017-04-19 |
Raindance Technologies, Inc. |
Enzyme quantification
|
WO2012170740A2
(en)
|
2011-06-07 |
2012-12-13 |
University Of Hawaii |
Biomarker of asbestos exposure and mesothelioma
|
WO2012170742A2
(en)
|
2011-06-07 |
2012-12-13 |
University Of Hawaii |
Treatment and prevention of cancer with hmgb1 antagonists
|
ES2653247T3
(es)
|
2011-06-09 |
2018-02-06 |
Curna, Inc. |
Tratamiento de enfermedades relacionadas con la frataxina (FXN) mediante inhibición del transcrito antisentido natural al gen FXN
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
US9725490B2
(en)
|
2011-07-29 |
2017-08-08 |
Tokushima University |
ERAP1-derived peptide and use thereof
|
MX370814B
(es)
|
2011-09-02 |
2020-01-08 |
Univ California |
Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
|
EA029151B1
(ru)
|
2011-09-06 |
2018-02-28 |
Курна, Инк. |
ЛЕЧЕНИЕ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С АЛЬФА-СУБЪЕДИНИЦАМИ ПОТЕНЦИАЛЗАВИСИМЫХ НАТРИЕВЫХ КАНАЛОВ (SCNxA), С ПОМОЩЬЮ МАЛЫХ МОЛЕКУЛ
|
US20140323907A1
(en)
|
2011-10-28 |
2014-10-30 |
Jason Frazier |
Methods for drug delivery
|
PT2790687T
(pt)
|
2011-12-16 |
2018-11-13 |
Poseida Therapeutics Inc |
Moduladores de trpc4 para uso no tratamento ou prevenção da dor
|
CA3191015A1
(en)
*
|
2012-02-07 |
2013-08-15 |
Vibrant Holdings, Llc |
Substrates, peptide arrays, and methods
|
JP6253596B2
(ja)
|
2012-02-16 |
2017-12-27 |
ザ ペン ステイト リサーチ ファンデーション |
アシル補酵素a:リゾカルジオリピン・アシル基転移酵素1(alcat1)の発現、機能または活性の阻害物質を同定する方法
|
EP2825209B1
(en)
|
2012-03-14 |
2018-08-29 |
University of Central Florida Research Foundation, Inc. |
Neurofibromatoses therapeutic agents and screening for same
|
TR201815503T4
(tr)
|
2012-03-15 |
2018-11-21 |
Curna Inc |
Beyin kaynaklı nörotrofik faktör (bknf) ile ilişkili hastalıkların doğal antisens transkriptinin bknf'ye inhibisyonu ile muamelesi.
|
US20150087628A1
(en)
|
2012-04-10 |
2015-03-26 |
The Regents Of The University Of California |
Compositions and methods for treating cancer
|
WO2013162772A2
(en)
|
2012-04-24 |
2013-10-31 |
University Of Miami |
Perforin 2 defense against invasive and multidrug resistant pathogens
|
US9399019B2
(en)
|
2012-05-09 |
2016-07-26 |
Evonik Corporation |
Polymorph compositions, methods of making, and uses thereof
|
WO2013184645A2
(en)
|
2012-06-04 |
2013-12-12 |
The Scripps Research Institute |
Novel phenyl glyoxal probes
|
EP3184121A3
(en)
|
2012-07-25 |
2017-09-27 |
Salk Institute For Biological Studies |
Lipid membranes with exposed phosphatidylserine as tam ligands, use for treating autoimmune diseases
|
CA2922849A1
(en)
|
2012-08-31 |
2014-03-06 |
Ixchel Pharma, Llc |
Agents useful for treating obesity, diabetes and related disorders
|
AU2013323426A1
(en)
|
2012-09-26 |
2015-04-23 |
The Regents Of The University Of California |
Modulation of ire1
|
US10006909B2
(en)
|
2012-09-28 |
2018-06-26 |
Vibrant Holdings, Llc |
Methods, systems, and arrays for biomolecular analysis
|
US20140094432A1
(en)
|
2012-10-02 |
2014-04-03 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
AU2013204200B2
(en)
|
2012-10-11 |
2016-10-20 |
Brandeis University |
Treatment of amyotrophic lateral sclerosis
|
EP2912194B1
(en)
|
2012-10-26 |
2019-05-08 |
Memorial Sloan-Kettering Cancer Center |
Androgen receptor variants and methods for making and using
|
US20140120116A1
(en)
|
2012-10-26 |
2014-05-01 |
The Chinese University Of Hong Kong |
Treatment of cancer using smad3 inhibitor
|
US10286376B2
(en)
|
2012-11-14 |
2019-05-14 |
Vibrant Holdings, Llc |
Substrates, systems, and methods for array synthesis and biomolecular analysis
|
RU2015126651A
(ru)
*
|
2012-12-10 |
2017-01-16 |
Фред Хатчинсон Кэнсер Рисёрч Сентер |
Способы скрининга
|
EP2934572A4
(en)
|
2012-12-20 |
2016-11-23 |
Biomatrica Inc |
FORMULATIONS AND METHODS FOR STABILIZING PCR REAGENTS
|
WO2014124339A2
(en)
|
2013-02-07 |
2014-08-14 |
The Regents Of The University Of California |
Use of translational profiling to identify target molecules for therapeutic treatment
|
WO2014127328A2
(en)
|
2013-02-15 |
2014-08-21 |
Vibrant Holdings, Llc. |
Methods and compositions for amplified electrochemiluminescence detection
|
US9227978B2
(en)
|
2013-03-15 |
2016-01-05 |
Araxes Pharma Llc |
Covalent inhibitors of Kras G12C
|
US9428537B2
(en)
|
2013-03-15 |
2016-08-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
tRNA derived small RNAs (tsRNAs) involved in cell viability
|
CA2909721A1
(en)
|
2013-04-19 |
2014-10-23 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Lone star virus
|
US9950036B2
(en)
|
2013-08-21 |
2018-04-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mood and stress related disorders
|
US10626178B2
(en)
|
2013-08-21 |
2020-04-21 |
Raz Yirmiya |
Treatment of mood and stress related disorders
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
JO3805B1
(ar)
|
2013-10-10 |
2021-01-31 |
Araxes Pharma Llc |
مثبطات كراس جي12سي
|
US9644037B2
(en)
|
2013-10-18 |
2017-05-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibodies that specifically bind ataxia telangiectasia-mutated and RAD3-related kinase phosphorylated at position 1989 and their use
|
US10280169B2
(en)
|
2013-12-11 |
2019-05-07 |
Biogen Ma Inc. |
Biaryl bruton's tyrosine kinase inhibitors
|
US10919929B2
(en)
|
2013-12-11 |
2021-02-16 |
Sloan-Kettering Institute For Cancer Research |
Glucocorticoid inhibitors for treatment of prostate cancer
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
US11193176B2
(en)
|
2013-12-31 |
2021-12-07 |
Bio-Rad Laboratories, Inc. |
Method for detecting and quantifying latent retroviral RNA species
|
KR102460549B1
(ko)
|
2014-03-04 |
2022-10-28 |
페이트 세러퓨틱스, 인코포레이티드 |
개선된 재프로그래밍 방법 및 세포 배양 플랫폼
|
WO2015136509A2
(en)
|
2014-03-14 |
2015-09-17 |
Genesis Theranostix Korlatolt Felelossegu Tarsasag |
Diagnostic and therapeutic targets for preeclampsia and closely related complications of pregnancy
|
EP3154338B1
(en)
|
2014-06-10 |
2020-01-29 |
Biomatrica, INC. |
Stabilization of thrombocytes at ambient temperatures
|
JO3556B1
(ar)
|
2014-09-18 |
2020-07-05 |
Araxes Pharma Llc |
علاجات مدمجة لمعالجة السرطان
|
WO2016049568A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Methods and compositions for inhibition of ras
|
WO2016049524A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
BR112017021869A2
(pt)
|
2015-04-10 |
2018-12-11 |
Araxes Pharma Llc |
compostos quinazolina substituídos e métodos de uso dos mesmos
|
EP3283462B1
(en)
|
2015-04-15 |
2020-12-02 |
Araxes Pharma LLC |
Fused-tricyclic inhibitors of kras and methods of use thereof
|
CA2983224A1
(en)
|
2015-04-24 |
2016-10-27 |
Agena Bioscience, Inc. |
Multiplexed method for the identification and quantitation of minor alleles and polymorphisms
|
CN107787371B
(zh)
|
2015-04-24 |
2022-02-01 |
基纳生物技术有限公司 |
检测和定量次要变体的并行式方法
|
US10196701B2
(en)
|
2015-06-01 |
2019-02-05 |
The Penn State Research Foundation |
Hepatitis B virus capsid assembly
|
US20160370380A1
(en)
*
|
2015-06-16 |
2016-12-22 |
Pharmaseq, Inc. |
Combinatorial antibody diagnostic
|
WO2016209772A2
(en)
|
2015-06-22 |
2016-12-29 |
Proteovista Llc |
Snp arrays
|
US10782304B2
(en)
|
2015-06-24 |
2020-09-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for detecting protein-protein interactions
|
US10144724B2
(en)
|
2015-07-22 |
2018-12-04 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use thereof
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
US10882847B2
(en)
|
2015-09-28 |
2021-01-05 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
US10858343B2
(en)
|
2015-09-28 |
2020-12-08 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
WO2017058768A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
WO2017058915A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
WO2017058807A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
US10689356B2
(en)
|
2015-09-28 |
2020-06-23 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
EP3356354A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
SG11201802957PA
(en)
|
2015-10-16 |
2018-05-30 |
Fate Therapeutics Inc |
Platform for the induction & maintenance of ground state pluripotency
|
JP2018533939A
(ja)
|
2015-10-19 |
2018-11-22 |
アラクセス ファーマ エルエルシー |
Rasの阻害剤をスクリーニングするための方法
|
CN108779097A
(zh)
|
2015-11-16 |
2018-11-09 |
亚瑞克西斯制药公司 |
包含取代的杂环基的2-取代的喹唑啉化合物及其使用方法
|
EP4242628A3
(en)
|
2015-12-08 |
2023-11-08 |
Biomatrica, INC. |
Reduction of erythrocyte sedimentation rate
|
US9988357B2
(en)
|
2015-12-09 |
2018-06-05 |
Araxes Pharma Llc |
Methods for preparation of quinazoline derivatives
|
WO2017139329A1
(en)
|
2016-02-09 |
2017-08-17 |
Alexander Krantz |
Site-selective functionalization of proteins using traceless affinity lables
|
WO2017172979A1
(en)
|
2016-03-30 |
2017-10-05 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use
|
US10646488B2
(en)
|
2016-07-13 |
2020-05-12 |
Araxes Pharma Llc |
Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
|
WO2018036503A1
(en)
|
2016-08-25 |
2018-03-01 |
The Chinese University Of Hong Kong |
Fecal bacterial markers for colorectal cancer
|
CN110036010A
(zh)
|
2016-09-29 |
2019-07-19 |
亚瑞克西斯制药公司 |
Kras g12c突变蛋白的抑制剂
|
US10726944B2
(en)
|
2016-10-04 |
2020-07-28 |
International Business Machines Corporation |
Recommending novel reactants to synthesize chemical products
|
JP2019534260A
(ja)
|
2016-10-07 |
2019-11-28 |
アラクセス ファーマ エルエルシー |
Rasの阻害剤としての複素環式化合物およびその使用方法
|
MX2019007030A
(es)
|
2016-12-15 |
2020-01-15 |
Univ California |
Composiciones y metodos para el tratamiento del cancer.
|
WO2018140599A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
Benzothiophene and benzothiazole compounds and methods of use thereof
|
US11136308B2
(en)
|
2017-01-26 |
2021-10-05 |
Araxes Pharma Llc |
Substituted quinazoline and quinazolinone compounds and methods of use thereof
|
EP3573971A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
|
EP3573954A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
|
EP3573967A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused hetero-hetero bicyclic compounds and methods of use thereof
|
WO2018170464A1
(en)
|
2017-03-17 |
2018-09-20 |
The Johns Hopkins University |
Targeted epigenetic therapy against distal regulatory element of tgfb2 expression
|
US11555031B2
(en)
|
2017-03-20 |
2023-01-17 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
CN110651036A
(zh)
|
2017-03-20 |
2020-01-03 |
健诺西生物科学公司 |
治疗方法
|
EP3630746A1
(en)
|
2017-05-25 |
2020-04-08 |
Araxes Pharma LLC |
Compounds and methods of use thereof for treatment of cancer
|
EP3630745A2
(en)
|
2017-05-25 |
2020-04-08 |
Araxes Pharma LLC |
Covalent inhibitors of kras
|
WO2018218069A1
(en)
|
2017-05-25 |
2018-11-29 |
Araxes Pharma Llc |
Quinazoline derivatives as modulators of mutant kras, hras or nras
|
US10538808B2
(en)
|
2017-05-26 |
2020-01-21 |
Vibrant Holdings, Llc |
Photoactive compounds and methods for biomolecule detection and sequencing
|
WO2019046791A1
(en)
|
2017-09-01 |
2019-03-07 |
The Johns Hopkins University |
TARGETED EPIGENETIC THERAPY FOR AERIAL CONDITION OF AERTICAL HERITATION
|
EP3692073A4
(en)
|
2017-10-03 |
2021-05-26 |
Cedars-Sinai Medical Center |
METHOD OF TARGETING THE IMMUNE CHECK POINT PD1 SIGNAL PATH FOR TREATMENT OF LUNG FIBROSIS
|
WO2019090242A1
(en)
|
2017-11-04 |
2019-05-09 |
Advanced Proteome Therapeutics Inc. |
Composition and method for modifying polypeptides
|
US20220412979A1
(en)
|
2018-10-29 |
2022-12-29 |
Genocea Biosciences, Inc. |
Treatment methods
|
US20210395751A1
(en)
|
2018-10-31 |
2021-12-23 |
The University Of Sydney |
Compositions and methods for treating viral infections
|
WO2020097261A1
(en)
|
2018-11-06 |
2020-05-14 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
New compositions and methods for treating beta-globinopathies
|
EP3917571A4
(en)
|
2019-01-31 |
2022-10-12 |
Agency For Science, Technology And Research |
CNX/ERP57 INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CANCER
|
US20220249559A1
(en)
|
2019-05-13 |
2022-08-11 |
Iovance Biotherapeutics, Inc. |
Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
RU2699563C1
(ru)
*
|
2019-05-29 |
2019-09-06 |
Федеральное государственное бюджетное учреждение "Петербургский институт ядерной физики им. Б.П. Константинова Национального исследовательского центра "Курчатовский институт" (НИЦ "Курчатовский институт-ПИЯФ) |
Модифицированный синтетический аналог природного опиоидного пептида энкефалина
|
DE102020202529A1
(de)
*
|
2020-02-27 |
2021-09-02 |
Robert Bosch Gesellschaft mit beschränkter Haftung |
Verfahren zur Identifikation einer Wirkstoffkombination
|
US11965162B2
(en)
|
2020-04-16 |
2024-04-23 |
The Johns Hopkins University |
MicroRNA and inhibitors thereof and methods of treatment
|
WO2023081167A2
(en)
|
2021-11-02 |
2023-05-11 |
The Regents Of The University Of California |
P-selectin mutants and modulation of integrin-mediated signaling
|
WO2023086969A2
(en)
|
2021-11-12 |
2023-05-19 |
Ichor Medical Systems Inc. |
Treatment methods
|
WO2023146807A1
(en)
|
2022-01-25 |
2023-08-03 |
The Regents Of The University Of California |
Vegf mutants and modulation of integrin-mediated signaling
|